1219274-96-0
1219274-96-0
Chemical Structure
Clopidogrel-d4 sulfate
- CAS No.: 1219274-96-0
- Formula:C16H14D4ClNO6S2
- Molecular Weight:423.92
IUPAC Name: methyl 2-(2-chlorophenyl-3,4,5,6-d4)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate
InChIKey: FDEODCTUSIWGLK-QZFMBAIXSA-N
SMILES: O=S(O)(O)=O.COC(C(C1=C(C([2H])=C([2H])C([2H])=C1[2H])Cl)N2CC3=C(SC=C3)CC2)=O
Biological Activity: Clopidogrel-d4 (sulfate) is the deuterium labeled Clopidogrel sulfate[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Clopidogrel-d4 sulfate | Clopidogrel-d4 (sulfate) is the deuterium labeled Clopidogrel sulfate. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Clopidogrel-13C,d3 sulfate | Clopidogrel-13C,d3 sulfate is the deuterium and 13C-labeled (±)-Clopidogrel (bisulfate) (HY-107867). (±)-Clopidogrel bisulfate is a platelet P2Y12 receptor inhibitor and an adenosine diphosphate (ADP) receptor antagonist. (±)-Clopidogrel bisulfate inhibits the binding of ADP to its receptors on the membranes of platelet cells, and blocks ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. (±)-Clopidogrel bisulfate reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression. (±)-Clopidogrel bisulfate has anti-inflammatory effects. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(Rac)-Clopidogrel-d3 sulfate | (Rac)-Clopidogrel-d3 (sulfate) is deuterium labeled Clopidogrel (sulfate). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(Rac)-Clopidogrel hydrogen-d9 sulfate | (Rac)-Clopidogrel hydrogen-d9 sulfate is the deuterium labeled (±)-Clopidogrel (bisulfate) (HY-107867). (±)-Clopidogrel bisulfate is a platelet P2Y12 receptor inhibitor and an adenosine diphosphate (ADP) receptor antagonist. (±)-Clopidogrel bisulfate inhibits the binding of ADP to its receptors on the membranes of platelet cells, and blocks ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. (±)-Clopidogrel bisulfate reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression. (±)-Clopidogrel bisulfate has anti-inflammatory effects. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-Clopidogrel bisulfate | 99.39% | (±)-Clopidogrel bisulfate is a platelet P2Y12 receptor inhibitor and an adenosine diphosphate (ADP) receptor antagonist. (±)-Clopidogrel bisulfate inhibits the binding of ADP to its receptors on the membranes of platelet cells, and blocks ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. (±)-Clopidogrel bisulfate reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression. (±)-Clopidogrel bisulfate has anti-inflammatory effects. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
